Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
3626
Ellington Financial
EFC
$1.75B
| $1.56M | ﹤0.01% |
113,182
-36,429
| -24% | -$464K |
|
3627
First Community Bankshares
FCBC
$925M
| $1.56M | ﹤0.01% |
52,508
+26,743
| +104% | +$703K |
|
|
APCA
3628
DELISTED
AP Acquisition Corp
APCA
| $1.56M | ﹤0.01% |
145,000
| – | – |
|
3629
NETSCOUT
NTCT
$2.84B
| $1.56M | ﹤0.01% |
50,355
-138,389
| -73% | -$4.07M |
|
3630
Box
BOX
$4.8B
| $1.55M | ﹤0.01% |
52,750
-25,911
| -33% | -$718K |
|
3631
Ouster
OUST
$2.5B
| $1.55M | ﹤0.01% |
+313,399
| New | +$1.64M |
|
3632
PUT
Hercules Capital
HTGC
$3.27B
| $1.55M | ﹤0.01% |
104,500
+32,300
| +45% | +$443K |
|
3633
Northwest Bancshares
NWBI
$2.25B
| $1.54M | ﹤0.01% |
145,445
-169,778
| -54% | -$1.89M |
|
3634
Ducommun
DCO
$2.66B
| $1.54M | ﹤0.01% |
35,359
-24,014
| -40% | -$1.13M |
|
3635
iShares MSCI USA Momentum Factor ETF
MTUM
$24.4B
| $1.54M | ﹤0.01% |
10,642
-14,859
| -58% | -$2.09M |
|
|
NVEE
3636
DELISTED
NV5 Global
NVEE
| $1.53M | ﹤0.01% |
55,396
+38,140
| +221% | +$936K |
|
3637
Stem
STEM
$52.4M
| $1.53M | ﹤0.01% |
13,394
-54,470
| -80% | -$5.41M |
|
|
SHCO
3638
DELISTED
Soho House & Co
SHCO
| $1.53M | ﹤0.01% |
281,902
-85,704
| -23% | -$540K |
|
3639
Utah Medical Products
UTMD
$232M
| $1.52M | ﹤0.01% |
16,356
+8,205
| +101% | +$773K |
|
|
SPR
3640
PUT
DELISTED
Spirit AeroSystems
SPR
| $1.52M | ﹤0.01% |
52,200
+1,000
| +2% | +$28.8K |
|
3641
NatWest
NWG
$73B
| $1.52M | ﹤0.01% |
248,354
-97,097
| -28% | -$638K |
|
3642
WaFd
WAFD
$2.67B
| $1.52M | ﹤0.01% |
+57,190
| New | +$1.58M |
|
3643
PUT
Bio-Rad Laboratories Class A
BIO
$10.4B
| $1.52M | ﹤0.01% |
4,000
+1,800
| +82% | +$733K |
|
3644
Marvell Technology
MRVL
$195B
| $1.52M | ﹤0.01% |
25,359
-7,315
| -22% | -$355K |
|
|
SII
3645
Sprott
SII
$3.42B
| $1.51M | ﹤0.01% |
+46,751
| New | +$1.62M |
|
3646
Ziff Davis
ZD
$1.91B
| $1.51M | ﹤0.01% |
+21,615
| New | +$1.48M |
|
|
GTHX
3647
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.51M | ﹤0.01% |
608,065
-267,069
| -31% | -$730K |
|
3648
Bank7 Corp
BSVN
$497M
| $1.51M | ﹤0.01% |
61,700
+3,953
| +7% | +$93.9K |
|
3649
Arteris
AIP
$1.08B
| $1.51M | ﹤0.01% |
+221,514
| New | +$1.2M |
|
3650
Patrick Industries
PATK
$2.68B
| $1.51M | ﹤0.01% |
28,307
-24,733
| -47% | -$1.16M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.